Physician profile
Chanun D Park
NPI 1629038161
$1,093.39
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $513 · 2020: $412 · 2021: $17.13 · 2022: $151.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $240.60 | 2019-2022 | |
| Novo Nordisk INC | $145.24 | 2019-2020 | |
| Pfizer INC. | $128.92 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $101.53 | 2019-2020 | |
| Lilly USA, LLC | $88.93 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $83.60 | 2019-2020 | |
| Amarin Pharma, INC. | $74.04 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $37.73 | 2019-2020 | |
| Amgen INC. | $34.51 | 2020-2021 | |
| Sunovion Pharmaceuticals INC. | $16.92 | 2019 | |
| Horizon Therapeutics Plc | $16.85 | 2020 | |
| Astellas Pharma US INC | $15.71 | 2022 | |
| Novartis Pharmaceuticals Corporation | $15.70 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $14.77 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.02 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scilex Pharmaceuticals INC. | $11.73 | 2019 | |
| Therapeuticsmd, INC. | $11.53 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $11.36 | 2019 | |
| Merck Sharp & Dohme LLC | $11.17 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chanun Park listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.